A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Bekaii-Saab, T
  • Starodub, A
  • El-Rayes, B
  • O'Neil, B
  • Shahda, S
  • Ciombor, K
  • Noonan, A
  • Hanna, Wael
  • Sehdev, A
  • Shaib, W
  • Mikhail, S
  • Neki, A
  • Oh, C
  • Li, YZ
  • Li, W
  • Borodyansky, L
  • Li, CJ

publication date

  • June 2017